|
|
| 2017, Vol. 26(5): 582-587 DOI: 10.3760/cma.j.issn.1004-4221.2017.05.023 | ||
| Progress in the application of rituximab in treating primary mediastinal B-cell lymphoma | ||
| Xu Liming,Yuan Yajing,Wang Peiguo,Wu Gang | ||
| Department of Radiation Oncology and Anesthesia,Tianjin Medical University Cancer Institute& Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer,Tianjin 300060,China (Xu LM,Wang PG,Yuan YJ);Cancer center,WuhanUnion Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China (Wu G) | ||
| Received 2017-01-18 Revised null | ||
| Supporting info | ||
| null | ||
|
